NASDAQ:ZYNE

Zynerba Pharmaceuticals Insider Trades

$4.18
-0.15 (-3.46 %)
(As of 04/15/2021 10:24 AM ET)
Add
Compare
Today's Range
$4.15
Now: $4.18▼
$4.36
50-Day Range
$4.06
MA: $4.66▼
$7.03
52-Week Range
$3.12
Now: $4.18▼
$9.00
Volume6,961 shs
Average Volume5.04 million shs
Market Capitalization$172.43 million
P/E RatioN/A
Dividend YieldN/A
Beta2.83

Insider Trades

Zynerba Pharmaceuticals (NASDAQ:ZYNE) Insider Buying and Selling Activity

Insider Ownership Percentage: 11.10%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Insider Buying and Selling by Quarter


Zynerba Pharmaceuticals (NASDAQ ZYNE) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/22/2018John P ButlerDirectorBuy5,000$6.43$32,150.005,000  
8/6/2018Armando AnidoChairmanBuy15,000$5.96$89,400.00352,512  
8/6/2018James E FickenscherCFOBuy8,518$5.97$50,852.4620,718  
8/6/2018Terri B SebreePresidentBuy3,800$5.79$22,002.00182,546  
5/30/2018Michael RappMajor ShareholderBuy5,885$10.45$61,498.25  
5/2/2018Michael RappMajor ShareholderBuy15,000$10.46$156,900.00  
3/22/2018Michael RappMajor ShareholderBuy10,000$9.28$92,800.00  
1/2/2018Michael RappMajor ShareholderBuy15,000$12.99$194,850.00  
10/23/2017Michael RappMajor ShareholderBuy25,745$9.94$255,905.30  
10/19/2017Michael RappMajor ShareholderBuy44,255$9.59$424,405.45  
5/15/2017Armando AnidoChairmanBuy5,000$19.70$98,500.00336,012  
5/12/2017James E FickenscherCFOBuy5,200$19.82$103,064.0012,200  
12/29/2016Michael RappMajor ShareholderBuy10,000$15.85$158,500.001,354,115  
12/7/2016James E FickenscherCFOBuy7,000$14.08$98,560.003,000  
8/16/2016Suzanne M HanlonInsiderSell3,000$10.53$31,590.0039,893  
(Data available from 1/1/2013 forward)
This page was last updated on 4/15/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.